Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

7 results
Display

Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C

Jung CH, Um SH, Kim TH, Yim SY, Suh SJ, Yim HJ, Seo YS, Choi HS, Chun HJ

BACKGROUND/AIMS: Peginterferon plus ribavirin remains a standard therapy for patients with chronic hepatitis C (CHC) in Korea. We investigated the efficacy and long-term outcome of peginterferon and ribavirin therapy in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus

Lee HJ, Choi JW, Kim TN, Eun JR

Adefovir dipivoxyl (ADV) effectively suppresses hepatitis B virus (HBV) replication but exhibits nephrotoxicity with severe hypophosphatemia when administered at a high dosage. This is the first report of severe hypophosphatemic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current Status and Clinical Course of Hepatitis C Virus in Korea

Kwon JH, Bae SH

  • KMID: 1767540
  • Korean J Gastroenterol.
  • 2008 Jun;51(6):360-367.
The mortality due to chronic liver disease, including liver cirrhosis and hepatocellular carcinoma (HCC), ranks as one of the highest in Korea. The prevalence rates of hepatitis C virus (HCV)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Usefulness of Serum alpha-fetoprotein (AFP) as a Marker for Hepatocellular Carcinoma (HCC) in Hepatitis C Virus Related Cirrhosis: Analysis of the Factors Influencing AFP Elevation without HCC Development

Kim KA, Lee JS, Jung ES, Kim JY, Bae WK, Kim NH, Moon YS

  • KMID: 1113479
  • Korean J Gastroenterol.
  • 2006 Nov;48(5):321-326.
BACKGROUND/AIMS: Serum alpha-fetoprotein (AFP) is frequently used for the diagnosis of hepatocellular carcinoma (HCC). Most available data concerning AFP came from studies of patients with chronic hepatitis B or...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of Adefovir Dipivoxil in Patients with Decompensated Liver Cirrhosis with Lamivudine Resistance Compared to Patients with Compensated Liver Disease

Moon W, Choi MS, Moon YM, Paik SW, Lee JH, Koh KC, Yoo BC, Rhee JC, Shim SG

  • KMID: 760590
  • Korean J Hepatol.
  • 2005 Jun;11(2):125-134.
BACKGROUND/AIMS: Adefovir dipivoxil is effective in patients with lamivudine-resistant hepatitis B virus (HBV). However, little is known about its role in Korean patients with decompensated liver cirrhosis. We retrospectively...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy and Safety of Long-term Lamivudine Therapy in the Patients with Decompensated Liver Cirrhosis Secondary to Hepatitis B

Park TW, Park YM, Bae SH, Jang JW, Nam SW, Choi JY, Yoon SK, Cho SH, Yang JM, Han NI, Ahn BM, Lee YS, Lee CD, Park DH

  • KMID: 863118
  • Korean J Hepatol.
  • 2002 Dec;8(4):428-435.
BACKGROUND/AIMS: Lamivudine use in patients with decompensated cirrhosis B has been reported to improve the hepatic function and often delay the need for liver transplantation. In the present study,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Therapeutic Efficacy of Lamivudine in Patients With Hepatitis B Virus-Related Decompensated Cirrhosis in Korea

Jung S, Suh DJ, Park HJ, Park YH, Song HG, Lee HC, Chung YH, Lee YS

  • KMID: 863117
  • Korean J Hepatol.
  • 2002 Dec;8(4):418-427.
BACKGROUND/AIMS: Although several clinical trials have suggested that lamivudine treatment can be very effective in patients with decompensated HBV-associated cirrhosis, its role and clinical efficacy are still uncertain because...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr